TY - JOUR
T1 - N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community
T2 - The hisayama study
AU - Doi, Yasufumi
AU - Ninomiya, Toshiharu
AU - Hata, Jun
AU - Hirakawa, Yoichiro
AU - Mukai, Naoko
AU - Ikeda, Fumie
AU - Fukuhara, Masayo
AU - Iwase, Masanori
AU - Kiyohara, Yutaka
PY - 2011/12
Y1 - 2011/12
N2 - Objective-Few studies have examined the association between natriuretic peptides and the incidence of cardiovascular disease (CVD) in Asian populations. Methods and results-A total of 3104 community-dwelling Japanese individuals aged 40 years without history of CVD were followed up for 5 years. A total of 127 CVD events were identified. The age-and sex-adjusted incidence of CVD increased with increasing N-terminal pro-brain natriuretic peptide (NT-proBNP) levels (<55, 55-124, 125-399, and 400 pg/mL) at baseline and was significantly higher even in subjects with a modest increase. This association remained robust even after adjustment for other potential risk factors (55-124 pg/mL: multivariate-adjusted hazard ratio=1.85 [95% CI 1.07-3.18], P=0.03; 125-399 pg/mL: 2.98 [95% CI 1.65-5.39], P<0.001; 400 pg/mL: 4.54 [95% CI 2.22-9.29], P<0.001). The multivariate-adjusted hazard ratios for the development of total CVD and its subtypes, coronary heart disease and stroke, were significantly increased by a 1 SD increment of the log NT-proBNP concentrations and were nearly equal among CVD subtypes. Similar findings were observed for stroke subtypes of ischemic stroke and intracerebral hemorrhage but not subarachnoid hemorrhage. The effects of the 1 SD increment in log NT-proBNP values were comparable in subjects with and without other cardiovascular risk factors, except for sex. The area under the receiver operating characteristic curve was significantly (P=0.006) increased by adding NT-proBNP values to the model including other potential risk factors. Conclusion-Elevated NT-proBNP levels were shown to be a significant risk factor for the development of CVD and its subtypes in a general Japanese population, independently of other cardiovascular risk factors.
AB - Objective-Few studies have examined the association between natriuretic peptides and the incidence of cardiovascular disease (CVD) in Asian populations. Methods and results-A total of 3104 community-dwelling Japanese individuals aged 40 years without history of CVD were followed up for 5 years. A total of 127 CVD events were identified. The age-and sex-adjusted incidence of CVD increased with increasing N-terminal pro-brain natriuretic peptide (NT-proBNP) levels (<55, 55-124, 125-399, and 400 pg/mL) at baseline and was significantly higher even in subjects with a modest increase. This association remained robust even after adjustment for other potential risk factors (55-124 pg/mL: multivariate-adjusted hazard ratio=1.85 [95% CI 1.07-3.18], P=0.03; 125-399 pg/mL: 2.98 [95% CI 1.65-5.39], P<0.001; 400 pg/mL: 4.54 [95% CI 2.22-9.29], P<0.001). The multivariate-adjusted hazard ratios for the development of total CVD and its subtypes, coronary heart disease and stroke, were significantly increased by a 1 SD increment of the log NT-proBNP concentrations and were nearly equal among CVD subtypes. Similar findings were observed for stroke subtypes of ischemic stroke and intracerebral hemorrhage but not subarachnoid hemorrhage. The effects of the 1 SD increment in log NT-proBNP values were comparable in subjects with and without other cardiovascular risk factors, except for sex. The area under the receiver operating characteristic curve was significantly (P=0.006) increased by adding NT-proBNP values to the model including other potential risk factors. Conclusion-Elevated NT-proBNP levels were shown to be a significant risk factor for the development of CVD and its subtypes in a general Japanese population, independently of other cardiovascular risk factors.
UR - http://www.scopus.com/inward/record.url?scp=81755184140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81755184140&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.111.223669
DO - 10.1161/ATVBAHA.111.223669
M3 - Article
C2 - 21921261
AN - SCOPUS:81755184140
SN - 1079-5642
VL - 31
SP - 2997
EP - 3003
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 12
ER -